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DNA mismatch repair (MMR) is the key process which ensures the incorporation 
of correct nucleotides during DNA replication by recognizing and removing of 
incorrectly paired nucleotides from DNA. DNA replication can introduce a mismatched 
nucleotide at a rate of 10-5 to 10-6 nts per replication cycle. If this mismatch is not 
corrected, then it becomes a permanent mutation after the next round of replication. 
Understanding the MMR mechanism can yield important insights into many aspects of 
human health, like the emergence of cancer and drug resistance in bacteria. To overcome 
experimental challenges with studying this process in living cells, we have developed a 
new method to enrich the rare genomic mutations by genotypic selection in a way that 
allows us to study the mismatch repair process in Escherichia coli, a model organism for 
MMR. We have shown the maximum 705,000-fold enrichment of DNA with a mutation 
even after a 10-6 times dilution by DNA with the wild-type sequence in vitro. After 
further optimization, we could then use this technique to directly measure MMR activity 
occurring in living E. coli (in vivo). We expect this technique will open up new 
opportunities and research directions to study MMR-like processes in E. coli as well as 
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1.1 Introduction to the Thesis: 
 
For my master’s thesis, I have been developing new biotechnologies to study how 
cells avoid genetic mutations during replication. This mutation avoidance is a Mismatch 
Repair (MMR) process which is a key guardian of genetic information. Proteins 
associated with MMR recognize mismatched nucleotides on the DNA, then remove and 
restore the original genetic information before the incorrect nucleotide can be passed on 
to the next generation. Here, we have developed a molecular technique to isolate rare 
mutations from a population in a way that allows us to directly quantify MMR activity as 
it occurs in living cells (in vivo). This technique makes use of a ‘genotypic’ screen, so we 
can isolate the rare mutations from the DNA itself, rather than ‘phenotypic’ screens that 
require those mutations to change the phenotype of the organism. In our technique, we 
continuously degrade unmutated or wild-type DNA using a thermostable restriction 
enzyme while using a polymerase chain reaction (PCR) to enrich the DNA with the 
mutation. First, we validated this approach to enrich the rare mutations on the plasmid 
DNA containing mutations of the recognition site of the thermostable restriction enzyme 




We found this approach produced a maximum of a 705000-fold enrichment of the 
mutated to wild-type DNA. Then, we applied this approach to a technique to study MMR 
in living Escherichia coli, a model organism to study MMR by using a gene-editing to 
introduce mismatched nucleotides directly into its genome. Previous approaches to this 
technique used a phenotypic screen to identify if the mismatch had been repaired, but for 
the first time, we could use genotypic selection. Here, the data and the analysis of the 
experiment and a detailed description of the protocol is described and discussed. The 
results suggest that this approach could be a powerful new tool to address several 
questions about how MMR is coordinated in living cells that would otherwise be nearly 
impossible to study. 
1.2 DNA Replication and DNA Damage Repair In Escherichia coli: 
 
1.2.1 DNA Replication In E.coli: 
 
DNA stores the genetic information in living organisms and serves as a template 
for replication and transcription. The E. coli genome contains over 4.6M basepairs (bps) 
[11]. Replication of chromosomal DNA is a well-orchestrated process requires the 
assembly and action of molecular machines known as replisome that coordinate all the 
necessary enzymatic activities for DNA replication. DNA replication in E.coli initiates at 
the origin of replication [12] and proceeds bidirectionally resulting in two “replication 
forks” that travel in opposite directions from the origin. In 1963, John Cairns [13] 
reported evidence of replicating the chromosomal DNA with two replication forks, the 




At each of these sites, parental DNA must be unwound into the two template 
strands that are copied simultaneously with DNA polymerase by extending preexisting 
primers from the 3’-OH end. This process is highly efficient and well maintained. At the 
replication fork, the two nascent DNA strands, known as ‘leading’ and ‘lagging,’ are 
synthesized differently. The leading strand is synthesized continuously, while the lagging 
strand is synthesized discontinuously as short Okazaki fragments [14]. Both strands are 
carried out by the replisome even if they differ in their processing nature.  
DNA replication starts when DnaA recognizes and binds to specific sequences 
within the OriC region and unwinds that region. Then, DnaA interacts with DnaB 
helicase in loading the DnaB-DnaC complex on each strand. DnaG is a primase which 
produces primers which will be extended during replication. DnaG function dissociates 
DnaC-DnaB complex and then DnaB helicase unwinds parental DNA strand by 
interactions with cellular replication enzymes, DNA polymerase III holoenzyme and 
primase as primers have formed that help in extension and duplication of the 
chromosome [15]. The replisome duplicates DNA with a very low mutation rate of 10-5 to 
10-6- bp misincorporation of nucleotides per genomic replication [16]. Erroneous or 
unrepaired mismatches become permanent mutations if they are not repaired. 
1.2.2 Repair of Misincorporated Nucleotides During Replication: 
 
DNA Mismatch Repair (MMR) pathway is involved in the repair of mis-
incorporated nucleotides due to errors in replication or incorrect recombination between 
non-identical DNA, preventing the permanent incorporation of these mismatches into the 




mismatched nucleotides. Loss or mutation of genes involved in this repair system leads to 
dramatic increases of spontaneous mutations that can cause harmful effects to the cell 
[17]. This system is well studied and characterized in the E.coli and consists of different 
mutator (Mut) proteins that coordinate to accurately repair the mismatch. 
1.2.3 Proteins of The MMR Pathway: 
 
The MMR pathway proofreads newly replicated DNA and is coupled to the 
replication. In E.coli, MMR starts when a MutS homodimer binds to a mismatch. MutS 
recognizes all types of DNA mismatches, except for dC-dC mismatches [18] or 
nucleotide insertion/deletions (indels) larger than 3 nucleotides [19]. MMR is initiated by 
the binding of MutS to a mismatch: MutS binds to different mismatches from highest 
binding to weakly binding according to: dG-dT, dA-dC, dA-dA, dG-dG >  dT-dT, dT-dC, 
dA-dG >> dC-dC [19],[20],[21], where dC-dC [7] is weakly recognized and poorly 
corrected by MMR system. After binding to mismatch, MutS recruits the MutL protein 
and they slide along the DNA strand together [18], [22] and recruit the MutH protein. 
Activated MutH has endonuclease activity and it nicks the newly synthesized DNA 
strand can be distinctly differentiated from methylated template strand at d(GATC) sites 
to initiate the repair process because the newly synthesized DNA is still hemi-methylated 
at those sites. MutL loads helicase UvrD [23] at the site of nick which uses this single-
strand break as the entry point to unwind the strand and generated single-stranded DNA 
is bound by single-stranded binding protein and protected from the nuclease attack [24]. 
Now, depending on the site generated relative to the mismatch, if it is at 3’-side 




will be activated and shred the strand up to mismatch. The resulting single-stranded gap 
undergoes DNA synthesis and ligation by DNA polymerase III holoenzyme, SSB and 
DNA ligase [25]. The efficient process of the digestion and resynthesis of the DNA 
strand between nick and the erroneous nucleotides, which can be separated by hundreds 
of base pairs, is called Long Patch Repair (LPR) [26].  
1.2.3.1 Mismatch Recognition ATPase MutS:  
 
The protein MutS directly interacts with the DNA strand and binds to mismatched 
nucleotides. It is a 95kDa protein with 835 amino acids and in solution exists as a blend 
of dimers and tetramers. The N-terminus and the C-terminus of MutS have distinct roles 
in the functioning of the protein. The N-terminus has a DNA binding motif through 
which it directly interacts with the mismatch on the DNA strand and has a MutL 
interaction domain. The conserved Phe-39 residue of MutS enters the DNA helix at 
mismatched nucleotides. The C-terminus is required for the oligomerization and thus 
specifies the stoichiometry of MutS during the repair. The protein also has an ATPase 
domain as binding and hydrolysis of ATP is necessary for its function. ADP-bound MutS 
specifically recognizes a mismatch and binds to DNA. MutS possesses a highly 
conserved walker type-A nucleotide-binding motif which is involved in ATP binding and 
hydrolysis. In the MutS N-2 and N-3’ nucleotide-binding motifs are unique that 
recognizes the four nucleotides on the DNA. N-2 is involved in ATP hydrolysis.  
This MutS-mismatch binding reduces the affinity of MutS to DNA and triggers 
ADP-ATP exchange [27]. This ATP binding to the MutS functions as a checkpoint and 




along the DNA molecule. In the presence of homoduplex, this ATP will act as “anti-
DNA-binding” as shown in Figure 1 [1]. Thus, mismatch in the DNA acts a nucleotide 
exchanging factor and this is crucial in one of the models of repair [28], [29], [30]. This 
protein also interacts with other components of the MMR system like MutL and the beta 
replication clamp. 
 
Figure 1. MutS ATPase Activity and Its Effects [1] 
 
  
(A) When Muts binds to the DNA and finds the DNA as homoduplex (no mismatches), 
MutS will not proceed for MMR. (B) MutS recognizes the DNA as heteroduplex 
(containing a mismatch) then after binding of ATP to MutS will convert it into the 




1.2.3.2 MMR ‘Matchmaker’ Protein MutL: 
 
Protein MutL is a 67kDa protein with 615 amino acids and is another ATPase that 




sliding clamp on a double-stranded DNA that undergoes further ATP exchange and 
recruits MutH. The N-terminal of MutL have domains for binding ATP and beta clamp of 
the DNA polymerase while the C-terminal is important for dimerization and also 
recruitment of other protein components [31]. 
1.2.3.3 Nicking Endonuclease MutH: 
 
MutH is a single-strand endonuclease which is recruited after a MutS/MutL 
complex formation and cuts near an adjacent d(GATC) on daughter strand. It is a 25kDa 
and exists in a monomeric form. The N-terminus regulates the activity of a cleft that 
binds the DNA helix. The C-terminal works in concert with the MutL which exerts a 
force on the bound DNA helix to shift it towards the catalytic site of the MutH [32] and 
consequently facilitates the endonuclease activity of the MutH. 
1.2.3.4 Repair Helicase UvrD: 
 
UvrD is a helicase that unwinds the mismatched DNA in 3’ to 5’ direction after 
MutH has cleaved it. UvrD participating in many cellular processes including DNA 
metabolism and mismatch repair [33].  
1.2.3.5 Exonucleases and Polymerases for Excision and Re-Synthesis: 
 
The action of the UvrD leads to the formation of single-stranded DNA(ssDNA) 
and this is digested by different exonucleases. These enzymes exhibit specificity towards 
the 3’ or the 5’ end of the DNA. ExoI, ExoVII, ExoX are specific to the 3’ terminal while 
ExoVII and RecJ are specific for the 5’ terminal of the ssDNA [34]. Single-Strand 




DNA Polymerase III holoenzyme participates in E. coli DNA replication and is 
required for re-synthesizing the DNA strand [35]. The alpha catalytic subunit of the Pol 
III binds the MutS/MutL complex. Another component of the DNA Pol III is the beta 
clamp and a clamp loader. The clamp slides along the DNA Pol III on the DNA strand 
from the 3’ and increases its processivity. The beta clamp has binding domains for 
multiple different components like DNA ligase, MutS/MutL complex. Specifically, MutL 
has clamp binding sites on the N-terminus as well as a certain region of the C-terminus 
[36].  
1.2.4 Coordination of Mismatch Repair Across Long Patches of DNA: 
 
Although the different types of MMR proteins and their function are known by in 
vitro studies, the mechanism by which they intracellularly coordinate excision and 
resynthesis of the DNA between the mismatch and a distant d(GATC) site is still 
unknown. However, there are three main proposed models for this coordination are: 
1.2.4.1 The Stationary Model: 
 
In this model, the DNA helix undergoes bending upon binding of MutS undergo 
the mismatch on the DNA strand. The looping of the DNA brings the two distant 
mismatch and the d(GATC) sites into close proximity. The ATP binding to the MutS help 
confirms the heteroduplex and further provides validation for the strand excision in the 
following steps. Studies by Junop et. al have shown that simultaneous binding of the ATP 






1.2.4.2 The Translocation Model: 
 
In this model, the binding of ATP to the MutS lowers its affinity for the mismatch 
in the DNA strand. This reduction in the affinity by the ATP hydrolysis causes the 
unidirectional movement of the MutS proteins along the DNA double helix. This 
movement leads to the formation of DNA loop that helps in the discriminating of the 
strand [38]. 
1.2.4.3 The “Molecular Switch” Model: 
 
In this model, the binding of MutS to the DNA mismatch triggers a change in the 
confirmation that causes a release of the ADP and binding of the ATP also called the 
ATP exchange that again causes a conformation change that leads to the formation of a 
MutS sliding clamp. The subsequent excision events are triggered by ATP binding rather 
than the hydrolysis of the bound ATP [39]. 
How DNA mismatch repair is coordinated intracellularly is still the subject of 
debate. Molecular details of MMR process coordination in vivo with respect to its 
location on the DNA still needs to be established based on these above-proposed models. 
We are interested in finding these molecular details using newly developed 
biotechnologies.  
1.2.5 Other Major Mechanisms of DNA Repair in E. coli: 
 
A genetic mutation can occur in a cell by errors during replication, recombination, 
or DNA repair [40], but also from direct chemical damage to the DNA molecule. These 




repair pathways that may also interact with MMR proteins. There are primarily two types 
[41],[42] of damage to DNA:  
1.2.5.1 Spontaneous or Endogenous Damage: 
 
Firstly, depurination or depyrimidination occurs when a base is lost, making the 
sugar/ phosphate backbone labile leading to strand breaks. The loss of base erases the 
genetic information from that site. Secondly, deamination of bases causes loss of amino 
group from the nucleotides. Due to this, cytosine converts to uracil which pairs with 
adenine instead of guanine. Thirdly, DNA replication and transcription create an 
overwinding problem which creates supercoiling of the DNA. This supercoiling needs to 
be relieved and this is done by enzymes like topoisomerases. These enzymes introduce a 
strand break to release the stress. Normally, this break is repaired by replication 
machinery but under some conditions like the presence of topoisomerase inhibitors or the 
failure in cell cycle this strand break is not repaired. Finally, oxidative damage is caused 
by the reactive oxygen species (ROS) produced by cellular respiration and metabolism 
that oxidize the nucleosides like Guanine (G) and Adenine (A) and converts them to 
derivatives like 8-oxo-dG and 8-oxo-dA. 
1.2.5.2 Environmental or Exogenous Damage: 
 
Ionizing radiation like gamma- rays or X-rays cause direct or indirect effects. 
When the radiation interacts directly with the DNA, the electrons cause phosphodiester 
bond dissociation due to the molecular resonance making the backbone labile causing 




leading to DNA damage. UV radiation forms cyclobutene pyrimidine dimers (CPDs) and 
6-4 photoproducts. These dimers block the replication and transcription machinery. 
Chemicals like alkylating agents disrupt the H-bonding of the bases by adding 
alkyl groups. Bulky adducts like Benzopyrene when metabolically activated distort the 
DNA double helix. The other compounds involved are intercalating agents and enzyme 
inhibitors. 
These different type of DNA lesions can cause a variety of mutations and so it 
becomes critical for the cell to maintain the genome stability. In order to facilitate this, 
the cell has evolved various mechanisms to repair the DNA damage. Distinct types of 
DNA damage are repaired (Figure 2) by specific proteins or groups of specific proteins. 
The first pathway is a direct reversal which does not need the strand synthesis but 
directly reverses the effect of the damage like CPDs by UV radiation and alkylated bases 
by alkylating agents. Enzymes like alkyltransferase [43] remove the alkyl groups from 
the DNA. Photoactivation process uses photolyases to reverse the CPDs [44].  
The second pathway is Base excision repair (BER) repair the damages like 
oxidation, deamination or base loss which do not distort the DNA double helix. BER was 
discovered when Thomas Lindahl first identified E.coli uracil- DNA Glycosylase (ung). 
DNA Glycosylase recognizes the damaged base and removes it subsequently generating 
an abasic site. The AP endonuclease chews the short segment surrounding the abasic site 
and DNA Pol synthesizes the complementary sequence and the ligase then seals it [45], 




which repairs single-nucleotide damage or long patch repair which repairs a stretch of 2- 
10 nucleotides [48].  
The third pathway is Nucleotide Excision repair (NER) and was initially 
discovered in 1964 by Bill Carrier and Dick Setlow in E.coli [49] About two decades 
later, the uvr genes were cloned by Aziz Sancar and others [50], [51], [52] which further 
strengthened our understanding of the prokaryotic NER. The repair of CPDs and the 
photo- products that cause the distortion in the DNA double helix are models for studying 
NER.  
In prokaryotes, the DNA damage is detected by UvrA along with UvrB, where 
UvrB identifies the precise location of the lesion and forms a site where the subsequent 
UvrC nuclease binds. UvrC cuts few nucleotides upstream and downstream from the site 
of the lesion so that UvrD can remove that portion out of the helix [53].  Further, DNA 
Pol recruits the complementary nucleotides with ligase sealing the nicks [54].   
The fourth pathway is Mismatch Repair (MMR) which is described above.  
In addition to this repair which involves either no strand break or single-strand breaks, 
there is also the Double-Strand Break (DSB) repair mechanisms. DSBs are induced by 
ionizing radiation and chemical agents [55]. The two major pathways involved are Non-
homologous End Joining (NHEJ) and Homologous Recombination (HR). NHEJ is an 
important pathway but is not present in E. coli. HR is functional and well understood in 
E.coli. It utilizes the homologous chromosome as a template to repair the DSBs. The 5’ 
ends at the DSB undergo resection and then strand invasion to repair the DNA in an 




Double-stranded break repair (DSBR) pathway or Synthesis dependent strand annealing 
(SDSA). This is an error-free process, unlike the NHEJ [56].  
In E.coli two similar pathways function RecBCD and RecF. RecBCD is the main 
pathway by which bacteria carry out DSB repair and if it fails due to some mutations then 
RecF pathway takes over. The RecBCD is an enzyme with helicase-nuclease domains 
and its activity is mediated by a regulatory sequence called the Crossover Hotspot 
Instigator (Chi) [57]. After reaching the Chi sequence, the nuclease domain cuts the DNA 
strand and RecA is recruited on the 3’ end of the newly formed single strand. This 
binding of RecA is not a passive process but actively mediated by RecBCD enzyme 
complex [58].  RecA is a molecular machine responsible for finding the complementary 
sequence by strand invasion into the homologous chromosome [59].  Sometimes if HR is 
attempted between DNA that is not perfectly identical, incorrect HR is prevented by 




















Figure 2. Different Types of DNA Damaging Agents and The Repair Pathways 
 
 
The spontaneous errors cause base loss leading the formation of abasic site and 
alkylating agents cause methylation of thymine leading to the formation of uracil 
which mispairs with guanine. The oxidative damage caused by cellular and metabolic 
processes oxidizes guanine to 8-oxo-guanine. These lesions are repaired by the base 
excision repair pathway. The UV light Causes the formation of cyclobutane 
pyrimidine dimers (CPD) and the aromatic hydrocarbons when metabolized form 
bulky addicts that distort the DNA. These are repaired by nucleotide excision repair. 
The irradiation leads to the formation of single-stranded and double-stranded breaks in 
the DNA Helix repaired by Non-homologous end-joining and Homologous 
recombination. The defects in the replication error lead to the formation of mispairing 




1.2.6 Mutation and Antibiotic Resistance: 
 
Pathogenic bacteria acquire antibiotic resistance (ABR) through two 
fundamentally different genetic mechanisms: Horizontal Gene Transfer (HGT)  and 
Spontaneous mutations [61]. The resistant genes which are encoded within the genome 




released from a dead bacterial cell which can be incorporated in the host via 
transfection, transduction or HGT. These processes are primary means of spreading the 
ABR, but the mutation is essential for evolution and diversification of the genes. 
Spontaneous mutations occur during replication which makes bacteria resistant to the 
given antibiotics. In Mycobacterium tuberculosis, the bacterial cause of tuberculosis, 
the main mechanism of drug resistance is only spontaneous mutations. Genetic 
mutations arise via oxidative damage, alkylation damage and DNA replication. 
Replication errors are the result of a failure in base matching, proofreading and DNA 
mismatch repair, which act sequentially to ensure the fidelity of DNA. MMR pathway 
is crucial to maintain genome stability and avoiding mutations [62]. Bacteria with 
defects in the MMR pathway or with reduced ability to correct a mismatch have a 
higher probability of accumulating genetic mutations and recombination events, such 
bacteria are known as “Hypermutatable” or “Hypermutator” phenotype [63]. These 
hypermutator bacteria are indirectly selected for the favorable mutations with a 
changing environment, such as antibiotic resistance. Studies from clinically isolated 
bacteria have shown that 1% of the strains are mutators naturally which increase the 
adaptive response in bacteria. There is a need to investigate how MMR process is 











1.3 Microscopic and Nanoscopic Studies of E. coli MMR Reaction Mechanism: 
 
1.3.1 Single-Molecule Studies Of E.coli MMR Proteins: 
 
In vitro studies of purified systems from bacteria have yielded important 
insights into the MMR reaction. Reconstitution of E.coli systems in vitro was started in 
1983 when, the essential protein components associated with MMR were identified 
using biochemical analysis and heteroduplex DNA [64],[65]. By 1989, the whole MMR 
system was reconstituted in vitro by purifying all necessary proteins to the system [66]. 
These studies were done using simple biochemical analysis like restriction enzymes, 
electromobility shift assay and the protein structures were determined by 
crystallography [67]. The MutS crystal structure was solved by removing 53 amino 
acids from the 853 amino acid of the whole protein and it is known as MutSdelta800 
[68],[67].  
The interactions between individual MutS and MutL can be studied by a 
technique called Single-molecule Föster Resonance Energy Transfer (smFRET) [69] 
which uses a single donor and an acceptor fluorophore. This has made it possible to 
elucidate the mechanism of MMR and provide the evidence for Switch Sliding clamp 
of MMR. Use of smFRET or fluorescence Tracking (FT) into single-molecule 
applications provides extremely accurate nanometer (nm) distance measures between 
individual protein particles, for example, a donor molecule on MMR protein [70],[69] 
and an acceptor molecule on a mismatch containing DNA. The advantage of 




msecs and real-time based on the fluorescence. This helps determine intermediate 
factors or proteins associated with the process. 
Quantum Dots (QDs) are also helpful in real-time tracking of these single 
proteins. This single-molecule tracking and smFRET has revealed the interaction of 
MutS with DNA and other proteins [72],[73]. Other techniques like AFM (Atomic 
Force Microscopy), small molecule Flow-Stretching (smFS), single-molecule Total 
Internal Reflection Fluorescence (smTIRF) [22],[2], [74],[75] have revealed the MutS 
induces a DNA conformation change when it encounters a mismatch. Thus, with AFM 
studies, it was possible to determine the DNA structure change and stoichiometries [75] 
because of MutS interaction with the DNA backbone at the site of the mismatch. 
Also, the attraction of single-molecule studies was smFRET combined with 
TACKLE (Transition Analysis Combined with Kinetic Lifetime Examination) 
[76],[77], in which the idea was to separate two different fluorescently tagged 
molecules at a distance of few bps in the same DNA. Whenever the DNA undergoes 
any conformational change two molecules will be in closed proximity with each other 
and emit fluorescence using resonance energy transfer. With the help of this technique, 
they examined the kinetics of conformational changes of DNA induced by MutS 
protein by real-time monitoring. These studies also suggested quantitatively that MutS 
kinetics and dynamics will differ in the interaction with DNA mismatches based on the 




Moreover, single-molecule studies recently have shown with (smTIRF) 
[22],[2] studies on glass slides reveal more information upon the interaction of MMR 
proteins. Using this realtime microscopy technique they have shown that E.coli MutS 
mismatch recognition results in the formation of stable ATP-bound sliding clamp that 
diffuses along with the DNA randomly, which acts as a platform to recruit MutL and 
forms MutS-MutL search complex. MutL binding to ATP will form a long-lived sliding 
clamp of MutS-MutL on a mismatch that together recruits MutH introducing ssDNA 
breaks at newly replicated DNA strand. Further analysis reveals that long-lived MutL 
sliding clamps associates with UvrD and increases its ability to unwind the DNA at the 
break. 
This additionally suggests few more information about E.coli MMR like MutH 
and UvrD share overlapping interaction sites with MutL and also supports the previous 
finding that requirement of exonuclease digestion for MMR excision in E.coli is very 
rare and the majority of the strand excision is done by MutL-UvrD complex in the 
absence of ssDNA exonucleases. 
Figure 3 describes the entire process of MMR in E.coli studies revealed by 
smTIRF. These studies support the molecule switch/sliding clamp model [78] as an 
originally proposed model for E.coli. These studies reveal some difference to the 
original model that includes the scission of d(GATC) sites by MutS-MutL/MutH 
complex surrounding the mismatch and more detailing about the unwinding [78] of 




[79] of MutS-MutL and MutH generated DNA fragments displacement during MMR 
process, which increases the complexity of the system analysis [80] and makes it 
difficult for a researcher to determine the precise mechanism as repair will only be 
completed when mismatch containing portion will be removed and resynthesized as 
























(a) MutS (blue) and MutL (brown) cascading clamps recruit the MutH 
(green) protein to generate multiple strand cuts (red lightning bolts) on 
mismatched DNA at d(GATC) sites. (b) MutL loads the UvrD (yellow) 
protein on the cuts on mismatched DNA where it unwinds (red arrow) and 
rezips (green arrow) the DNA that again processed by SSBs. (c) when MutL-
UvrD unzipping reaches the MutH cut site near adjacent d(GATC) site, the 
SSB bound DNA fragment is generated between these cut sites. (d,e) even 
though the strand displacement between two adjacent d(GATC) is random, 




The DNA polymerase and ligase complete the MMR by resynthesizing the 




However, we will note that these reactions are performed in the absence of 
actively replicating DNA, so the conditions that this reaction might occur in a cell 
remain unclear. 
1.3.2 Single E.coli Cell Studies of MMR Activity: 
 
Study of mismatch repair in vivo is crucial. One of the studies of E.coli K-12 
strain [81] has shown how the absence of MMR proteins will accelerate the mutation 
acquisition in bacteria and also drug resistance in the absence of MMR components. 
However, the nature of MMR and its associated machinery have made it difficult to 
study this process in vivo. In addition to above-described techniques, the MMR process 
was also studied using a microfluidic chip to see how the dynamics of mutations take 
place in a cell over time.  
Uphoff [82] designed a microscopy-based approach to study the real-time 
mutagenesis in response to an alkylating agent (methylmethane sulfonate) and antibiotic 
treatments using microfluidics in a single E.coli cell. They found the stochastic 
expression of MMR genes with single-cell studies, describing how E.coli cells modulate 
mutagenesis. The chronology of mutagenesis and responses to genotoxic stress in (Figure 








Figure 4. Real-Time Mutagenesis in E.coli [3] 
 
 
(A) Mother machine (microfluidic chip) (B) parent cell and progeny cell coming out 
of the capillary, (C) G-T mismatch near the MutL-mYPET to track the response of a 
cell. (D) The events of mutagenesis and genomic stress in response to methylmethane 
Sulfonate (MMS). Van Houten and Kad PNAS | July 10, 2018 | vol. 115 | no. 28 
Copyright (2018) National Academy of Sciences 
 
 
Another protocol to visualize the dynamics and effects of mutations on fitness is 
developed by Robert et al. [83],[4], which has implemented mutation visualization (MV) 
and microfluidic mutation accumulation (μMA), which allow us to follow the occurrence 




with Yellow Fluorescent Protein (YFP). MV allows precise characterization of dynamics 
of point mutations created by replication errors in E.coli. Additionally, it also states the 
difference in the rate at which replication errors occur in a ‘single-cell’ and the ‘per-cell’ 
error rate of different subpopulations of cells because the MutL is associated with error 
repair and allows mutation detection.  
Figure 5 [4] describes at what frequency mutation occurs and they get fixed in 
E.coli cell. When an error occurs during the replication, only one of the four dsDNA 
molecules will carry the mutation. Therefore, in E.coli in minimal media conditions, a 
single replication cycle will generate 1/4 mutated progeny of a single cell progeny and 
this proportion can be lower in the rich media when doubling time is shorter than the time 
necessary to replicate the chromosome. As shown in Figure 5c, when there are six 
replication forks generated in the minimal media 1/4 of the progeny will have mutations. 
Figure 5d shows that in the rich medium this frequency is lower to 1/8 progeny to receive 
the mutation. 
Single-cell visualization can also be used to understand the replication dynamics 
in cells and its interactions with MMR proteins [84],[85] by engineering fluorescent 
domains on to DNA repair and replisome associated proteins, researchers have shown 
how leading and lagging strands are replicated [86], how replisomes and MMR proteins 
interact, single protein dynamics and DNA interactions [87], DNA replication fork 
dynamics with the help of nanoscopic fluorescence microscopy [88],[87],[84].   
Most of these studies are performed and give some important information on how 




Figure 5. Frequency of Error Incorporation During Replication Based on The 
Growth Medium in E.coli [4] 
 
 
(a)A mismatch (yellow star) base is inserted during one round of 
replication (red dot indicates the replisome) and is converted to a 
permanent mutation in the genome in the next round of replication 
leaving one mutated DNA among four. (b,c) when replication time is 
smaller than the doubling time of a cell then replication error was 
tracked as MutL-YFP spot in ¼ of the progeny in the minimal media. 
(d) When the cells are provided with rich medium and doubling time 
is shorter than the time required for a chromosome to replicate, 
frequency of progeny becomes 1/8 compare to minimal media.  
Copyright © 2019, Springer Nature 
 
 
1.4 Outstanding Questions About Mismatch Repair Activity in vivo: 
 
While in vitro experiments using purified MMR proteins can provide insights into 
their biophysical interactions using highly defined experimental conditions, these 




replicating DNA. In contrast, studies of MMR in living cells need to rely on the rare 
mismatches that are generated randomly through the cell or require additional mutagens 
to increase the probability of a mismatch. In those cases, the biochemical conditions are 
uncontrolled and often unknown. Additionally, in vivo (here referred to as in bacterial 
cell)  studies of MMR use as their measure the overall cellular mutation rate, rather than 
MMR activity itself. There is a need to elaborate the molecular details beyond these 
interactions, and to test whether the behavior observed in vitro occurs during intracellular 
MMR. For example:  
1. How is repair coordinated during replication? In vitro repair can be 
coordinated using d(GATC) sites from either side of the mismatch, but a study from 
Hasan and Leach [40] suggests that mismatch repair in cells is coordinated by the 
direction of replication.  
2. What is the stoichiometry of the repair complexes during repair in cells? 
For example, in vitro MutS can form tetramers, but Mendillo et al [89]. have shown that 
mutations that disrupt MutS tetramerization only modestly affect mutation rates during a 
rifampicin resistance assay. 
3. Under what conditions are each of the components of the MMR pathway 
necessary in the cell? For example, on the lagging strand, there are many breaks in the 
DNA, so MutH or d(GATC) sites might not be necessary to repair lagging strand 
mismatches if repair is coupled to replication.  





5. What is the kinetics of the MMR reaction in living cells? How important 
is the coupling to replication? 
6. How well conserved is this mechanism across different organisms with 
divergent MMR proteins? 
Investigating these questions will likely require a novel technique to quantify the 
MMR in vivo in a more controlled manner than spontaneous reporter assays. 




A biotechnological tool for gene editing, oligonucleotide recombination is one 
technique where we can introduce mismatched nucleotides into specific places along the 
genome of a living cell. During oligonucleotide recombination, a short single-stranded 
DNA (ssDNA) molecule called an oligonucleotide that is always complementary to one 
strand of the E. coli genome except for one or more mismatches can become integrated 
into the genome during replication. 
After the oligonucleotide is introduced into a cell, during replication it can get 
incorporated in the genome at the rate of 10-7 to 10-5 per transfected cell. If the beta 
recombinase from the λ phage is also expressed during transfection, oligonucleotide 
recombination efficiency increases to 10-5 to 10-3. Which is also known as lambda (λ) 
Red- mediated recombination [90]. 
 If those mismatches are not repaired by MMR, they become permanent 




coupled MMR processes in living E. coli cells while maintaining exact biochemical 
control over where that mismatch occurs.  
1.5.2 λ Red-Mediated Recombination: 
 
Lambda red mediated oligonucleotide recombination is also known as 
‘Recombination Engineering’ or ‘Recombineering’. Bacteriophage λ-red mediated 
recombination of dsDNA requires exo, bet and gam functions [90],[91] while 
recombineering with single-stranded DNA requires only beta-protein function which is 
shown in Figure 6 [5]. Ellis et al. [91], has shown the ability of λ protein beta to promote 
recombination between the chromosome and a synthetic ssDNA donor by confirming the 
hypothesis that λ beta is sufficient to perform oligonucleotide recombination. First-ever 
gene replacement eliminating the requirement of RecA [92],[93] was achieved using a 
multicopy plasmid expressing these proteins of bacteriophage λ in E.coli following the 
transfection of linear DNA substrates.  
This gene replacement was 15 to 130 times higher than recBC, sbcBC or recD 
recombinant strains. Furthermore, E.coli strain was constructed to replace recBCD gene 
with Plac
-bet exo operon and a kanamycin resistance cassette. This new strain was used to 
replace the gene higher rate of recombinants were observed compared to plasmid-
encoded λ-red. This has proven that cloning of the gene of interest before replacement is 
not necessarily required [90].  
λ Beta is a ssDNA binding protein which promotes annealing of complementary 
single strands and mediates the strand exchange in vitro [94],[6]. It has also shown that 




while performing reannealing of ssDNA with genomic DNA [95]. The Beta protein itself 
cannot mediate strand invasion of a dsDNA but it combines ssDNA to duplex DNA by 
strand annealing [6],[92]. Other proteins in the Red operon include λ Gam that inhibits 
the RecBCD function and its nuclease activity which protects electroporated DNA 
substrate [96],[97]. λ Exo is a ds-DNA dependent exonuclease which provides the 3’- 
overhangs for the as a substrate for efficient recombination by digesting 5’-> 3’ direction 
[98]. 
 
Figure 6. Model of Bacteriophage λ Mediated Single Strand Annealing [5] 
 
 
A ssDNA oligonucleotide recombination at replication fork 
on a lagging strand. This shows that the oligonucleotides 
are annealed to complementary ssDNA. Copyright © 2016, 






Additionally, it is also suggested that this recombination with ssDNA technology 
can be applied to a wide range of organisms concluded after successful oligonucleotide 
recombination in Saccharomyces cerevisiae [99] and E.coli [91].  
Figure 7 [6] shows the λ Beta protein-mediated strand exchange. In this 
experiment M13 DNA was used having radiolabeled 43-mer thermally annealed to it. 
The ssDNA oligo having 63-mer was introduced into the cell. The 63-mer DNA 
oligonucleotide had an additional 20 nucleotide and four mismatches at its 5’-side 
compare to 43-mer and its homology with 43-mer radiolabeled DNA.  
The strand displacement experiment was carried out and it showed the strand exchange of 
radiolabeled DNA by beta protein. 
 
Figure 7. The Displacement of Radiolabeled (32p) DNA by Beta-Protein  [6] 
 
 
This Figure shows the M13 genomic DNA where the radiolabeled 43-mer is thermally 
annealed. (-) strand is the 63-mer with mismatches (X). This process shows the strand 
exchange by beta protein in the end where radiolabeled DNA is removed from the 






When either of the strands of the genomic DNA was targeted by ssDNA oligo to a 
specific location on the chromosome the highest efficiency of recombination was 
achieved in the oligos that had complementarity to the lagging strand of the DNA 
[91],[100]. The studies have shown the highest efficiency of oligonucleotide 
recombination near Okazaki fragment means near the replication fork as shown in Figure 
8 [7]. This suggests that oligonucleotide recombination takes place at the DNA 
replication fork during replication. MMR deficient strains have shown the increased 
recombination [101] which suggest that mismatches introduced by oligonucleotides are 




















The illustration of MMR at a replication fork. The Okazaki fragment is shown on the 
lagging strand and the MutS binding to the mismatch generated after incorporation of 
ssDNA oligonucleotide (Red arrow)on the lagging strand. Methyl (CH3) groups are 
shown on the parental strand. The beta protein binds to the ssDNA oligos is shown for 
the illustration and this event of leading and lagging strand oligos is not occurring at 
the same time in one cell. This is the schematic of how beta mediated recombination 
occurs near the replication fork either on leading or lagging strand.  Costantino and 




The illustration of mismatch containing oligonucleotide incorporation and their 




Figure 9. Beta Mediated Oligonucleotide Recombination E.coli 
 
 
This Figure represents, how oligonucleotides are incorporated into the genome with beta 
recombinase to the complementary strand during replication. Then, once incorporated, 
this oligonucleotide will be replicated every time and thus some fraction of the cells will 




Moreover, three important points are noticed that supports the hypothesis that 
beta-mediated oligonucleotide recombination occurs at replication fork [7] during DNA 
replication [102], [5], [103]: 
1. The incorporation rates depend on whether the oligo is designed to bind to 
the lagging or leading strand template [91],[104],[86] because there are 30 times larger 
gaps present [7] in the lagging strand compare to the leading strand, so it is likely to see 




occurs during replication with the highest efficiency of oligonucleotide recombination 
occurring on the lagging strand [104]. 
2. Mutations to different proteins involved in replication alter the strand-
specific frequency of oligonucleotide recombination [105],[106].  
3. Oligonucleotides are subject to partial degradation from either 5’-side or 
3’-sides after annealing by exonucleases that are associated with DNA polymerase I and 
III. Thus, this evidence suggests that oligonucleotide recombination is affected by 
exonucleases present at the time of DNA replication[102].  
There is also significant evidence that these mismatches introduced during 
oligonucleotide recombination are repaired specifically by MMR proteins. There is an 
increased efficiency of oligonucleotide recombination when MMR proteins are 
inactivated or when the mismatch introduced is a dC-dC mismatch [107] or insertions 
and deletions (IDLs) more than 3bps, which are not recognized by MMR proteins [19]. It 
has been also reported that MutS cannot recognize the multiple mismatches as efficiently 
as a single mismatch [108] and high oligonucleotide recombination was achieved by 
changing 6-20 nucleotides in a row [109],[110]. This recombineering has been combined 
with other tools to develop new tools like MAGE [111],[112] (Multiplex Automated 
Genome Engineering) and TRMR [113] (Trackable Multiplex Recombineering). MAGE 
is unique in targeting many locations on the chromosome for modification in a single cell 
or across the cell population simultaneously. This has proven improved metabolic 




Oligonucleotide recombination has been demonstrated to be an effective gene-
editing technique in different organisms and cells [7],[114],[115]. Research carried in the 
past few years has demonstrated the ability of this recombineering tool to modify 
different cell types like archaea [116],[117],[118] human embryonic stem cells [119] and 
mycobacteria [120]. Oligonucleotide recombination in mycobacteria has also combined 
with another system like Bbx1 integrase and RecT to generate the library of insertion, 
deletions or fusions of a bacterial chromosome which is known as ORBIT [121] 
(oligonucleotide mediated recombineering followed by Bbx1 integrase targeting). 
Oligonucleotide recombination can also be combined with the CRISPR-Cas9 [122] tool 
to perform the chromosomal engineering by using Cas9 to introduce double-strand breaks 
at DNA without the mutation, increasing the probability of isolating a mutant. Thus, 
recombineering has advanced the genetic manipulation, genomic studies and metabolic 
engineering[123],[111] of bacteria and increases the possibility of eukaryotic cell genetic 
manipulations too.  
1.6 SPORE (Semi Protected Oligonucleotide Recombination) Assay: 
 
However, a challenge of using oligonucleotide recombination directly to study 
MMR is that incorporation rate is low and depends on the specific oligonucleotide 
sequence, where it is being integrated, and other factors.  
A modified form of oligonucleotide recombination is known as called a SEMI 
PROTECTED OLIGONUCLEOTIDE RECOMBINATION (SPORE) assay, was 
developed specifically to study MMR processes by allowing researchers to separate 




recombination and allows us directly to evaluate MMR in the living cells [8], [9] (Figure 
10). 
 
Figure 10. Original Demonstration of SPORE Assay on The Lagging Strand with 
Phenotypic Selection [8] 
 
 
(A) The oligos designed complementary to the lagging strand so that it will correct a 
synthetic STOP codon (TAG) in the galactose kinase gene galK, allowing bacteria 
with a successfully transformed oligonucleotide to survive in media with galactose 
as the only sugar source. Non-Template Strand (NT) and Template(T) strand. 
(B) The ‘control’ mismatch that corrects the galK gene is chemically protected from 
LPR by phosphorothioate bonds (Indicated by “*”). ‘probe’ mismatch is unprotected 
and located on one side of the control mismatch, so we can see how the repair is 




(C) Protocol for transfection of SIMD50 competent cells, which express the beta 
recombinase, with oligo 5’-GT & 3’-GT (where the probe mismatch is located on 
either the 5’ or 3’ side of the control mismatch, respectively). After transfection, the 
cells are grown on a galactose selective media which indicates a mutation of stop 
(TAG) codon. Then the grown cells are checked for the probe mutation by sequencing 
and then we can quantify the efficiency of repair with respect to MMR-deficient (mutS 
knockout, KO) strain. 
(D) mutS Wild type vs mutS KO sequencing results of the repair of G-T probe 
mismatch. Copyright © 2017, Oxford University Press 
 
 
During a SPORE assay [8],[9], a synthetic oligonucleotide is designed to contain 
multiple mismatches on the same oligo that are separated spatially. Among these 
mismatches, one is control mismatch which is chemically protected by phosphorothioate 
bonds (*) and the other two are unprotected, MMR-active ‘probe’ mismatches (Figure 
10). Those control mismatches are mismatches like dC-dC which do not excite the MMR 
response, and they are flanked by phosphorothioate bonds (*), the function of which is to 
protect the oligonucleotides against the degradation by exonucleases. These bonds also 
block long patch repair (LPR), which helps in separating the repair occurring from either 
5’ or 3’ end based on the location of the probe site relative to the control site. The 
hypothesis is that when we select for control mismatches which should be incorporated 
regardless of whether repair occurs, we can then look at the presence or absence of the 
probe mismatch to determine whether mismatch repair occurred. 
Figure 10 [8] is the demonstration of a SPORE assay which was based on the 
phenotypic selection of the mutation introduced by the control mismatch in the bacteria. 




1. G-T and T-T mismatches are repaired differently on the lagging strand. 
The G-T mismatches are recognized strongly by MutS while the T-T mismatches are 
weakly recognized. The repair is coordinated from the 3’-side of oligonucleotide (5’-side 
of the replicating DNA fragment. This also suggests the repair of G-T mismatches are 
two orders of magnitudes greater than T-T mismatches. 
2. The asymmetry was observed in G-T vs T-T mismatches with mutS 
mutant suggests that 3’- repair is coordinated by MutS tetramerization [124], while MutS 
dimer can coordinate the repair from 5’-side. One of the reasons for this conformational 
bias of MutS can be asymmetry in the replicated DNA [40].  The observed bias in the 
repair of T-T and G-T mismatch was unexpected as MutS crystal structure [125] has 
shown common binding mode across different mismatches, but this result [8] has proven 
that MMR may coordinate differently for the different types of mismatches. The 
quantitative analysis based on the SPORE assay data shows that tetramerization of MutS 
increased the 3’-repair rates 10-fold compared to the mutant form, which was incapable 
of forming tetramer. But 5’-repair rates remain the same. A mutation to disrupt MutS 
tetramerization but allow dimerization only affected mismatch repair from 3’-side but did 
not affect on 5’-coordinated repair [126].  
3. Another published study has proven the mechanism for lagging strand 
MMR with the help of SPORE assay [9] which shows the evidence that MutH 
independent MMR is coordinated from 3’-side in the direction of lagging strand while 




4. Researchers hypothesized that there were two different mechanisms of 
lagging strand repair in the same study:  
a) A tetrameric MutS assisted endonuclease independent mismatch repair 
which is coordinated from 3’-side of a mismatch.  
b) A dimeric MutS assisted endonuclease dependent mismatch repair. 
The above SPORE assay results are contrasting to what has been studied 
extensively with non-replicating DNA [127] in vitro because those studies found that 
MMR is bidirectional or can repair DNA equally from both 5’ and 3’ sides. 
A two-step model (Figure 11) [9] summarizes the relative repair efficiencies (RE), 
nature and directionality of MutH dependent and independent repairs from the SPORE 
assay. This two-stage model suggests for the repair of dG-dT mismatches on the lagging 
strand. Another possibility is that if replication-coupled MMR process is coordinated 
from 3’-of a mismatch fails, the second attempt of repair is made. In this second attempt 
(Figure 11 (B)) MutS dimer will become a diffusive sliding clamp on the DNA which 
will recruit MutL and then MutH and find for the nearest d(GATC) site to initiate the 
repair process. 
This model was suggested from the quantitative data of the SPORE assay. Which 
describes the repair of G-T on 5’ mismatches on oligos even if 3’-LPR is blocked. This 
suggests that while 3’-LPR is attempted first, there exist an efficient “backup” 











(A) A tetramer MutS assisted endonuclease independent MMR attempted at 
3’side which was initiated by MutS dimer, capable of tetramerizing later. 
(B) If this replication-associated MMR fails then MutS dimer will be converted 
into a sliding clamp which will diffuse randomly with MutLH complex to 




These two published studies [8],[9] of SPORE assay has given details about the 
following advantages of this technique over ‘recombineering’: 
1. It does not require a spontaneous phenotypic reporter assay 
[128],[129],[130] like rifampicin resistance phenotypic assay, which can result in false-
positives and provides evidence of overall mutation rate rather than MMR activity. 
2. It requires amplification of only targeted sites to identify the rare 
mutations, eliminating the need for whole-genome sequencing [64]. Also, this targeted 
site amplification will allow the researcher to perform next-generation deep sequencing 




3. It reduces the false-positive results by careful design of oligos having 
higher melting temperature with phosphorothioate bonds, this can be improved to 
<<0.1% by designing different oligonucleotides [8]. 
4. We can target different chromosomal locations in the organisms that have 
shown the success of oligonucleotide recombination [133],[134],[135],[136]. 
5. Introduction of phosphorothioate bonds [8],[9] few base pairs away from 
either 5’ or 3’ direction on the oligonucleotides protects the control mismatch from 
exonuclease digestion associated with DNA polymerase [102]. 
6. This assay allows us to monitor oligonucleotide recombination efficiency 
and MMR repair efficiency of individual probe mismatch, of LPR quantitatively from 5’ 
and 3’ direction [9]. 
7. This method is highly sensitive in a manner that can quantify the repair of 
T-T mismatch which are poorly recognized by MutS [8]. 
8. It has allowed the construction of a simple mathematical model to quantify 
the effects of MMR protein mutations different nucleotide mismatches and compare it to 
biochemical and spontaneous reporter assay [8]. 
In SPORE assay could likely be further improved by using Locked Nucleic Acids 
(LNAs) [137],[138] that contains a modified sugar residue with an addition of 2’-C, 4’-C-
oxymethylene linker [137] which maintains the ribose ring to 3’-endo conformation. 
DNA: LNA duplexes [139], [140] as the control mismatch. LNAs demonstrate increased 




LNAs have shown alteration of three nucleotides in E.coli and mouse embryonic 
stem cells successfully without activation of MMR [138]. LNAs hinders the MutS 
binding to the mismatch in vivo which can be useful in protecting oligonucleotide for 
specific mutation selection. This has provided another type of protection which can be 
useful to perform oligonucleotide recombination which may give an insight of MMR in 
vivo [138],[8],[9]. 
1.7 Developing an Improved SPORE Assay with Genotypic Selection of the Control 
Mismatch: 
 
We have seen above the unique features of SPORE assay to study the MMR in a 
cell. This assay is limited by its requirement for phenotypic selection of a bacteria which 
were selected to grow on a certain media as a result of the ‘control’ mutation, and it 
becomes very limiting when some gene selection gives false-positive results. For 
example, a published study [141] has demonstrated that more than once a kind of 
spontaneous mutation in E.coli bacteria help them to grow on rifampicin. In cases where 
the rate of spontaneous mutation approaches the rate of oligonucleotide incorporation, we 
will get false-positive results. When the false-positive rate approaches the rate of 
oligonucleotide incorporation, as in leading strand MMR, it cannot be used.  
Also, the phenotypic selection will create challenges in adapting the SPORE assay 
for studies in the Mycobacterium genus. Our lab is interested in elucidating a putative 
MMR-like process in Mycobacterium tuberculosis, the bacterial cause of tuberculosis. 
[142]. Antibiotic resistance in M. tuberculosis emerges as a result of genetic mutations 




understood. Unlike most other bacteria, M. tuberculosis and related organisms do not 
possess proteins with homology with canonical MutS/MutL proteins. Rather, in these 
bacteria, only one NucS/EndoMS [144] protein has been recently identified which is 
believed to play a role in an independently evolved mismatch repair-like process. We 
know that (canonical) MMR proteins inhibits recombination events and limits the 
mutation rate. We hypothesized that bacteria are modulating their gene expression of 
MMR proteins in the presence of antibiotic to acquire a drug resistance or there can be 
more recombination events occur which help them becoming resistant. We want to find 
the other proteins and involved in the MMR of these bacteria which are still unknown. 
These finding of MMR proteins and other unknown proteins in vivo will help the 
scientific community to design a better drug to inhibit one of the proteins involved in 
drug resistance of these bacteria.  
For my master’s thesis, we decided to develop a SPORE assay that uses a purely 
genotypic selection of mutant DNA. This would allow us to more easily study an unusual 
MMR process in Mycobacteria. Improving the sensitivity of the SPORE assay would also 
allow us to quantify the MMR on the leading strand where incorporation is much rarer, 
and also across different chromosomal locations without any need for phenotypic 
selection of bacteria. SPORE assay can also give us an idea about how different 
mismatches (dG-dT, dA-dC, dG-dA, dT-dC) affect the repair process and how they are 
coordinated.  
We were motivated by reports of the Depletion of Abundant nucleotide 




using restriction enzymes from a highly concentrated background of unmutated DNA. 
There are general problems associated with a clinical diagnosis of disease using next-
generation sequencing, so to develop a highly sensitive and cost-effective molecular 
diagnostic tool for clinical setup they used CRISPR-Cas9 technology to enrich samples 
containing rare mutations. Cas9 is an endonuclease from Streptococcus pyogenes which 
is guided by RNA composed of tracr-RNA and crRNA transcribed from the CRISPR 
(Clustered regularly interspaced short palindromic repeats) sequence [145],[146]. 
CRISPR-Cas9 uses these RNAs to degrade phage DNA with a complementary sequence 
to the crRNA from the host without harming the bacteria’s own genome. Their central 
idea (Figure 12) was to deplete ‘unmutated’ sequences using the gene-editing tool 
CRISPR-Cas9 [145],[146] before performing PCR so that, during a subsequent PCR 
amplification step they could selectively enrich the only DNA for KRAS mutant 
(c.35G>A,p.G12D) sequences.   
With pre-treatment by a Cas9 targeting the unmutated ‘wild-type’ DNA but not 
the mutated DNA, using DASH they saw a 60-fold increase of mutant sequences (Figure 
13) in 1:1000 ratio of mutant: wild type sequence ratio and no detection of mutated 













Figure 12. Depletion of Abundant Sequences by Hybridization [10] 
 
 
In this Figure, they have 
shown the target DNA 
(Orange) and Non-target 
DNA (Purple). The 
proportion of the Target 
to Non-Target sequence 
has shown very high in 
the next-generation 
sequencing library. The 
strategy of the technique 
is, adapters can only 
bind to the intact non-
target sequences as they 
cannot be cleaved by 
CRISPR Cas9. The 
target sequences which 
are cleaved by CRISPR 
Cas9 cannot be 
amplified as the adapter 
cannot bind to them.  
So, in the end, only 
enriched non-targets 
will be present in the 
final sequencing results. 












(A) Wild type allele of KRAS at 
glycine12 position and KRAS 
G12D mutated glycine 12 position 
(c.35G>A) which is responsible 
for malignancies. 
(B) Human genomic DNA with 
different ratios of wildtype to 
mutant KRAS treated with KRAS-
Cas9, Non-human guide RNA 
(Negative Control) and KRAS-no 
Cas9. The graph presented as a 
percentage count of WT and 
mutant allele sequence was carried 
out by Digital droplet PCR 
(ddPCR). Purple bars show the 
WT allele sequence and Blue bars 
indicate the mutant allele of 
KRAS G12D. The data shows that 
WT allele numbers are decreased 
after addition of Cas-9 to DASH 
(mentioned as KRAS DASH) 
compare to the other control 
where Cas-9 was not added 
(mentioned as DASH).  
(C) Inset represents the same data 
as Figure 13 B but as fold 
enrichment of mutant sequences of 
KRAS treated with Cas9 (Dark 
Blue) and KRAS not treated with 
Cas9 (Light Blue). Here, we can 
see that they could enrich the 
mutant allele detection from 10% 
to 81% (8.1-fold), 1% to 30% (30-
fold) and 0.1% to 6% (60 fold). 
0% indicates no enrichment of 
mutated sequence as it was only 
WT KRAS allele.  Copyright © 




We hypothesized (Figure 14) that if a restriction enzyme could continuously 
digest ‘unmutated’ DNA to prevent their enrichment during PCR, rather than just 
digesting one time before PCR, this technique would be significantly more sensitive and 
we could identify mutations from the SPORE assay that was much rarer than even 
1:1000. This would allow for more difficult experiments, like using the SPORE assay to 
study MMR on the leading strand or SPORE in mycobacteria. In this study, we used the 
ApeKI restriction enzyme, derived from hyperthermophilic organism Aeropyrum 
pernixKI (ApeKI) [147], which is highly thermostable restriction enzyme is most active 
at temperatures where PCR occurs (70-75 degrees C) [148]. The mutations introduced by 
our oligos using oligonucleotide recombination make DNA uncleavable by ApeKI 
restriction enzyme and thus we can do genotypic selection to study MMR using SPORE 
assay. In other words, the unmutated DNA would contain the recognition site for ApeKI 
(GCWGC, where W = “A” or “T”) while successful incorporation of oligos will have 
these sites mutated to GCTCC and GCACC. 
During my master's project, we measured the sensitivity of ApeKI enzyme under 
PCR conditions in vitro with plasmid DNA containing ‘mutated’ and ‘wild-type’ 
sequences. Then we check the ApeKI efficiency with genomic DNA after performing 
oligonucleotide recombination to mutate ApeKI sites. Finally, we have performed a 
SPORE assay in vivo and performed genotypic screens to demonstrate that we could use 
this technique to study MMR processes in living cells with very high sensitivity and 




Figure 14. Our Approach 
 
 
The elimination of un-mutated or targeted site cleavage by ApeKI with every cycle of 
PCR and simultaneous enrichment of mutated site or sequence that not recognized by 
of ApeKI will result in DNA for sequencing that is highly enriched for DNA 









1. Development and optimization of a method to selectively enrich the DNA 
of bacteria transformed by oligonucleotide recombination, without phenotypic selection: 
According to our hypothesis, we wanted to see the enrichment of selected 
mutations (GCWCC, W= A or T) on the genomic DNA after performing PCR by adding 
the ApeKI restriction enzyme to PCR reaction. The central idea of this experiment has 
been shown in the hypothesis (Figure 14). We first checked the efficiency of ApeKI 
restriction enzyme during PCR reaction using the plasmid DNA containing mutations on 
the recognition site for this restriction enzyme. So during the PCR reaction, this enzyme 
will only cut the DNA containing its recognition site (GCWGC, W  = A or T) but it 
would not cut the plasmid containing a mutation in this recognition site. After performing 
this experiment we found ApeKI restriction highly efficient in its function during a PCR 
cycle to enrich selective mutations across the plasmid DNA. Thus, this confirms the 
efficiency of ApeKI restriction enzyme and its ability to selectively enrich the mutations 




Then we perform the oligonucleotide recombination assay on two different genes 
to mutate the naturally present ApeKI recognition site (GCWGC, W = A or T) in the 
genome: galK and araD on E.coli genome. The oligos were designed to induce a single 
mutation in ApeKI recognition site (GCWCC, W= A or T) on the respective gene and 
they were complementary to the lagging strand of the DNA strand in the genome. The 
oligo targeted for galK gene was capable of inducing one mutated ApeKI recognition site 
on it while oligo targeting araD gene was capable of inducing mutations in two distinct 
ApeKI recognition sites separated by 4bps, as the E.coli naturally contains two ApeKI 
recognition sites on araD gene. We performed the genotypic selection to screen for the 
specific mutations on the genomic DNA after performing oligonucleotide recombination 
for both different gene locations. We found that oligo having two mutated ApeKI 
recognition sites had a better signal to noise ration after Sanger sequencing compared to 
the galK gene having one mutated ApeKI recognition site. Thus, we confirmed to move 
forward with oligos having two ApeKI mutated sites and we decided to carry the SPORE 
analysis on araD gene to study the MMR. 
2. A SPORE assay to study the MMR process using newly developed 
genotypic selection method to screen for the presence or absence of mismatches:  
We confirmed that ApeKI gives the best enrichment of selected mismatches on 






 SPORE assay [8], [9] was mainly designed to have protected control mismatches 
by phosphorothioate bonds so that it will not elicit the MMR action and also saves the 
oligonucleotides from being degraded by exonucleases. It was based on the phenotypic 
selection to screen for bacterial mutants after performing oligonucleotide recombination 
on the E.coli genome. Here, we studied of MMR process with Semi Protected 
Oligonucletoide Recombination with newly developed genotypic selection method was 
primarily attempted. We tried this assay on the araD gene but with two different oligos. 
Both the oligos were same in length as oligo was used for araD gene oligonucleotide 
recombination but these oligos contained the phosphorothioate bonds (*) at two control 
mismatches which induce the mutations in two ApeKI recognition sites. The other 
difference between these two oligos is that one of them contains the 5’dA-dC mismatch 
and 3’dC-dC mismatch while the second oligo contains 5’ dC-dC mismatch and 3’dA-dC 
mismatch. These oligos will help us to look at the direction that repair of dA-dC 









MATERIALS, METHODS, RESULTS AND DISCUSSION 
 
 
First, we validated that including ApeKI in a PCR reaction could allow us to 
selectively enrich DNA with mutated ApeKI target sites then measured the sensitivity of 
ApeKI enzyme in vitro with plasmid DNA. We checked the efficiency of ApeKI on 
genomic DNA by performing oligonucleotide recombination and selectively enriching 
successful recombinants. We optimized the technique to increase the sensitivity further. 
Lastly, we have performed a SPORE assay to study the MMR in vivo. 
3.1 Materials: 
 
Escherichia coli strain SIMD50 (W3110 galKtyr145UAG ΔlacU169 [λ cI857 
Δ(cro-bioA) (int-cIII<>bet)]) obtained as a generous gift of the laboratory of Don Court 
(National Cancer Institute, Frederick,  MD, USA).  Phusion polymerase (Pfu) Master Mix 
was obtained by New England Biolabs (Ipswich, MA, USA) and used for all PCR 
reactions. Gene Pulser(R)/MicroPulser(tm) Electroporation Cuvettes, 0.1 cm gap were 




Oligonucleotides were purchased from Integrated DNA Technologies, Inc. 
(Coralville, IA, USA) with standard desalting and used without further purification. 
Genome Isolation kits, Polymerase Chain Reaction (PCR) purification kits, and gel 
extraction kits were obtained by New England Biolabs (Ipswich, MA, USA). 
3.2 Experimental Procedure: 
 
3.2.1 Testing the Efficiency and Sensitivity of ApeKI Using Plasmid DNA: 
 
To begin, we first wanted to check whether ApeKI was active during PCR 
reaction conditions and, whether it would allow us to enrich not just mutated ApeKI sites 
by itself, but also if other flanking mutations (labelled (#) in Figure 15) on the same 
plasmid are also enriched. The enrichment of side mutations outside the (“control 
mutation) ApeKI site is a pre-requisite for SPORE assay that we will perform. We also 
wanted to measure how sensitive this technique was, and how rare the mutated ApeKI 
sites could be.  
We performed this experiment using a “Target” plasmid having ApeKI restriction 
site (“GCWGC”- W= ‘A’ or ‘T’), and a plasmid having mutated ApeKI site that we 
labelled “Non-Target” (“GGAGC”) plasmid that also contained 7 different nucleotides 
across about 100 bp outside the mutated ApeKI site [Figure 15 (Bottom Figure)], 
depending on the mutation.  
Samples were prepared by mixing Target plasmid and Non-Target plasmid to 
achieve Target: Non-Target of 100:1, 10,000:1 and 1,000,000:1 in reactions with a total 




For each mixture 50nM of plasmid DNA concentration was used as template 
DNA in a PCR reaction with primers 5’-CACTGGAGTTGTCCCAATTCTTG-3’ and 5’-
TCGCTGGGATTACACATGGC-3’ in 50μl of the PCR reaction, which was performed 
with two sets: 
Set 1- Target and Non-target without adding 1μl (5 units/μl) of ApeKI to the PCR 
reaction. 
Set-2 Target and Non-Target plasmid by adding 1μl (5 units/μl) of ApeKI to the 
PCR reaction. The PCR cycles were used for 25x cycles and unpurified samples were 
sent out for the Sanger sequencing at GENEWIZ (South Plainfield, NJ). 
3.2.1.1 Quantitative Analysis: 
  
The quantitative analysis of the Sanger sequencing results was performed using 
BioEdit software and MATLAB (Mathworks, Inc). The raw chromatogram data from the 
sequencing results were imported in BioEdit software and extracted into .txt files and 
imported into MATLAB. A code was written in MATLAB to extract the signal strength 
for each nucleotide channel at each called sequence peak. The signals for each channel 
were normalized by the mean signal intensity of that nucleotide channel across the region 
of interest, and the fraction of the signal intensity under each peak was assigned to the 
Target or Non-target plasmid for the samples treated with ApeKI and without ApeKI. 
This will give sequence comparison quantitatively that how much (%) of the sequence 




Figure 17 shows the enrichment of the Non-Target plasmid with the mutated 
ApeKI site as well as the flanking mutations on the same Non-Target plasmid DNA after 
completion of PCR reaction. 
 
Figure 15. The Compared Sequence of Two Distinct Plasmids 
 
 
The sequence alignment of a “Target” plasmid DNA with an ApeKI restriction site (top 
strand), and a “Non-Target” plasmid (bottom strand) with a mutated ApeKI site. Black 
square box indicates the focused mutation that we are attempting to selectively enrich 
from the  “Non-target” plasmid. (A) Sequence alignment between the “Target” plasmid 
and plasmid “Non-Target-5”. We also want to determine if ApeKI will enrich the 
flanking differences outside the restriction. (#) indicates the different mutated site 















Figure 16. Gel Image of PCR Amplified Products 
 
 
Plasmid DNA after PCR amplification with and without adding ApeKI with different 
ratios of Non-Target to Target plasmid DNA. This shows the DNA band of 331bps 
after PCR which shows the enrichment of desired sequence having side mutations as 

















Figure 17. Quantitative Enrichment of Non-Target (NT) Sequence Fraction from 
















This represents the enriched fraction of NT sequence before and after adding ApeKI to 
the PCR reaction. Blue bars indicate the fraction of NT sequence when ApeKI was not 
added in the PCR and Red bars represent the fraction of NT sequence from the pool of 
mixture after adding ApeKI to the PCR reaction. Above data, ratios of Target (T): Non-
Target (NT) in each reaction. (A) 1e2:1, (B) 1e4:1 and (C) 1e6:1. 
 
 
Here, we can see quantitatively that the Non-Target (NT) sequence is significantly 
enriched over Target (T) plasmid sequence after PCR with ApeKI in all the ratios. After 
ApeKI enrichment, Sanger sequencing revealed that the signals initially mixed as 1e2:1 
Target: Non-Target plasmids were on average 85.47% Non-Target sequence with a 
standard deviation of 8.27% across all sites that differ in sequence. 
This is a significant increase compared to the previous report of DASH using 





1e2:1 digested:non-targetted mixture (Figure 13). 1e4:1 dilutions were, after enrichment, 
79.32% non-target with a standard deviation 10.29% across all differing sites, and 1e6:1 
dilutions were, after enrichment 70.48% Non-Target sequence with a standard deviation 
of 15.52% across all sites. In summary, for 1e2:1, 1e4:1, and 1e6:1-fold dilutions, that is 
an enrichment of ~85-fold (compared to 30-fold using Cas9 DASH (Figure 13)), 7900-
fold, and 705000-fold enrichment, relatively. 
Conclusion: We have confirmed that ApeKI could be used to successfully 
enriching not just the mutated ApeKI site but the entire flanking sequence on the plasmid 
surrounding the site with high efficiency. This is a prerequisite for using this approach to 
study the MMR with genotypic selection in the SPORE assay. 
3.2.2 Testing the Efficiency of ApeKI to Enrich Successful Oligonucleotide         
Recombination Mutations in the E. coli Genome: 
 
To perform oligonucleotide recombination, E. coli strain SIMD50, which 
expresses the beta recombinase in a heat-inducible manner at 42⁰C, was transformed with 
ssDNA oligos and screened according to the new genotypic selection protocol using 
oligos complementary to the lagging strand of galK and araD genes of E.coli. We used 
sterile techniques to make electrocompetent E.coli cells.  
Bacterial colonies of SIMD50 were grown in 10ml Luria Broth (LB) overnight at 
30⁰C with shaking at 200rpm and next day, 0.5ml of growth solution was added to 35ml 
of the sterile LB in 50ml centrifuge tubes and grown further at 30⁰C at 200rpm until 0.4-
0.6nm O.D. of the bacterial culture was achieved. Then the tubes were heat-shocked at 




mins. The tubes were then spun in a centrifuge at 6500g for 7mins at 4⁰C and the LB 
gently decanted after centrifuge. Bacterial pellets were resuspended in 1ml of sterile and 
pre-chilled water and then pre-chilled 30ml of sterile water was added to the resuspended 
pellet and again centrifuged for 7mins at 4⁰C and 6500g in a centrifuge. The tubes were 
immediately removed and the supernatant was gently removed and bacterial pellets were 
again resuspended in the 1ml of water and transferred to the sterile pre-chilled 1.5ml 
microcentrifuge tubes and spun for 30secs at 4⁰C. then after discarding the supernatant 
the pellet again resuspended in 1ml of prechilled sterile water and spun for 30 secs at 
maximum (g) at 4⁰C. Then after discarding a supernatant pellet was resuspended in 200μl 
of prechilled sterile 15% glycerol and divided the competent cells into 1.5 
microcentrifuges each having 50μl of competent cells and stored at -80⁰C or used fresh 
by mixing 2μl of 100mM ssDNA oligos gently. The mixtures were electroporated at 
1.8kV using GenePulser electroporation system and immediately mixed with 1ml of 
prewarmed LB media after electroporation and grown for 30mins at 30⁰C with shaking in 
a shaking incubator. 30mins after recovery each tube was divided into two tubes with 
500μl of bacteria in each tube and grown for 15mins at 200rpm in 30⁰C shaker incubator 
and then after 15 mins, the samples were put on room temperature for 10mins more and 
then genome isolation protocol was performed using New England Biolabs (Ipswich, 
MA, USA) kit. The genotypic selection protocol shown in Figure 18 was performed after 





Figure 18. The Optimized Genotypic Selection Protocol 
 
 
After transfection with this oligo, we isolated E.coli genomic DNA. 100ng of genomic 
DNA were added to a PCR reaction, and primers used to enrich the targeted region by 
PCR with 25 cycles without adding ApeKI. Then a single band was confirmed on a gel 
and purified for the second round of PCR. 1ng of purified DNA was used for the 2nd 
round of PCR with 25 cycles. 
 
 
To validate that our approach could be used to enrich a genomic mutation 
introduced using the oligonucleotide recombination technique, we first performed 
oligonucleotide recombination using oligos we designed to have complementarity with 
lagging strand of galK gene. The oligo sequence 5’-CGT GCG TCA TAT ACT GAC 
TGA AAA CGC CCG CAC CCT TGA AGC TCC CAG CGC GCT CGA GCA AGG 
CGA CCT GAA ACG TA T GGG CGA G (Contains the mutated ApeKI recognition site 




with ApeKI site= (GCTGC, W= A or T) on the galK gene. Underline nucleotides on the 
sides ‘C’ represents the flanking mismatches. Recall that dC-dC mismatches are not 
recognized by MutS so we do not expect this oligonucleotide to excite MMR.  
As a baseline test of selection for successful recombinants, we made oligos 
strategically that can induce the mutation to the galK gene which mutates the ApeKI 
recognition site (yellow) from ‘GCTGC’ to ‘GCTCC’ through dC-dC mismatches (red, 
above). We then added flanking dC-dC mismatches (blue) outside of the ApeKI site to 
test whether those other mutations would be enriched along with the DNA with mutations 
in the ApeKI site. This time we did not select for a mutation with a premature stop codon 
on the galK gene as described in Figure 10 (used previously for phenotypic selection), 
but rather we are performing genotypic selection on the middle C. 
The protocol shown in Figure 18 was followed and then we prepared the 
following two sets of PCR samples with 5’-CTGTTGCGCATGAACTGGAC-3’ and 5’-
GCGCATAGAGGCATGAGACT-3’ primers. 
Reaction 1 (Figure 19 (TOP)): 1ng of amplified DNA to the 50μl PCR reaction 
for 25 cycles without adding ApeKI as control. 
Reaction 2(Figure 19 (Bottom)): 1ng of amplified DNA to the PCR reaction for 
25 cycles with ApeKI during the PCR cycle. 
After completion of PCR, the PCR sample was loaded on the agarose gel. We 
purified the amplified DNA and then we send it to GENEWIZ (South Plainfield, NJ) for 










Isolation of rare genetic mutation induced on galK gene by oligonucleotide 
recombination. (TOP) Sequencing of a gDNA amplicon without adding ApeKI 
during PCR cycle. (Bottom) Sequencing of a gDNA amplicon after adding the 




3.2.2.1 Quantitative Analysis: 
 
The raw chromatographs of the Sanger sequencing were processed as before to 
find the signal strength for each nucleotide channel present at the called sites of the 
introduced mutations. The code extracts the nucleotide numbers from the raw 






Table 1. Comparison of Quantitative Values from Sanger Sequencing 
Chromatographs of galK Gene Before and After Adding ApeKI 
 
 
The quantitative analysis of selectively enriched mutations selected for different 
positions on the oligonucleotides where one ApeKI recognition site was 
mutated. The data represents the mean value and standard deviation of the 
signal strength for the G and C nucleotide channels during Sanger sequencing at 
each targeted site without adding ApeKI (left) and after adding ApeKI enzyme 
(right) to the sample after oligonucleotide recombination. A G- means the 
ApeKI site is unmutated while a C is a mutation in the ApeKI site. 
 
 




Enrichment of GCTCC sequence from GCTGC (mean + standard deviation, n= 




shows that enriched with dG-to-dC mutations after addition of ApeKI during 
genotypic selection method. 
 
 
Oligonucleotide recombination with phenotypic selection typically results in 
mutational efficiencies on the order of 1-in-100, although to the best of our knowledge 
the true mutational frequency from genotypic screens from oligonucleotide 
recombination is not known but expected to be a lot lower. Figure 20 shows the 
enrichment of dG-to-dC mutations at the different positions targeted for mutation by the 
oligonucleotide either with or without ApeKI in the PCR reaction. In Table 1 we can see 
that the maximum enrichment of genomes with dG-to-dC mutations to between 11.14% 
to 18.23%.  
These results show the lower than expected enrichment of dG-to-dC mutations 
after oligonucleotide recombination. Inspection of the chromatograph of Sanger 
sequencing in Figure 19 revealed that a significant fraction of the enriched population 
had unintended mutations in the ApeKI mutated site, which likely limit. 
Conclusion: While we see selective enrichment of DNA with mutated ApeKI sites 
and the flanking mutations, Sanger sequencing also revealed other mutations in the 
ApeKI site that was not intentionally created by the incorporation of the oligo. These 
might have been present from natural variants in the E.coli population or, more likely, 
created from errors by the DNA polymerase during PCR.  
We hypothesized that if we have two ApeKI sites mutated then we can enrich the 
signal more efficiently. We found the araD gene in E. coli genome, where there are two 




designing oligonucleotides that would mutate these two ApeKI sites using the same 
oligonucleotide. 
3.2.3 Oligonucleotide Recombination With TWO ApeKI Sites in the Genome: 
 
The oligo complementary to araD lagging strand was designed with two dC-dC 
mismatches at the ApeKI restriction sites in the genomic DNA and two flanking dC-dC 
mismatches. The oligonucleotide sequence is CGT CAG TTA GCG CCG CAG TTA 
CCC GAT ATG CAC CAA ACG CTC CTG GAT AAA CAC TAT CTC CGT AAG 
CAT GGC GCG AAG GC where the mutations are shown with C and C nucleotides and 
flanking mutations are presented as C. This oligo resembles the oligo used in the SPORE 


































(A)Integration of an oligonucleotide to introduce mutations to two ApeKI sites 
during replication. It is the representation of how oligonucleotide incorporates into 
the genome that is complementary to the lagging strand. The lagging strand is 
extended in the opposite direction of the replication fork. The oligonucleotide 
(grey color) which is complementary to the lagging strand (light blue). Yellow 
color indicates the ApeKI restriction sites. Underline nucleotides represents the 
mutations that we are focusing on. (B) shows how oligonucleotide will bind to the 
complementary sequence in the genome of bacteria. Then after incorporation into 
the genome, it will stay permanent inside the genome and replicated as indicated 
above in every round of replication with that mutation. 
 
 
Oligonucleotide recombination was performed as mentioned earlier (Figure 18) 
and the same PCR with primers 5’-CAGGCGAAAGCCTTGTTCAC-3’ and 5’-
CATGGGGCAAAAATGCCGAA-3’, enrichment protocol was followed by genomic 
DNA isolation. The DNA samples after gel extraction were sent to the GENEWIZ (South 





Figure 22. Gel Image of PCR Amplified Products of araD Gene   
 
 
After 2nd round of PCR with and without the addition of ApeKI to the araD gene 
fragment. The gel was stained with SYBR Gold Stain and the single band was 
confirmed at 442 bp size. Here, the single bands from the gel were cut for further 
Sanger sequencing and analysis. 
 
 








(A)Sequencing of a gDNA amplicon without adding ApeKI during PCR cycle. (B) 
Sequencing of a gDNA after adding the ApeKI during the PCR cycle. Red arrows 
show and compare two Figure’s signal difference. Sequence difference can be seen 
between (A) and (B) with the highlighted nucleotides in the box. 
 
 
3.2.3.1 Quantitative Analysis:  
 
The raw chromatographs of the Sanger sequencing were processed as before with 
the results shown in Table 2. The data presented in the table is also represented in the 




















Table 2. Comparison of Quantitative Values from Sanger Sequencing 
Chromatographs of araD Gene Before and After Adding ApeKI 
 
 
The quantitative analysis of selectively enriched mutations selected for different 
positions on the oligonucleotides. The data represents the mean value and 
standard deviation of mutation at each site on the oligonucleotide without 




























Figure 24 shows the enrichment of dG-to-dC mutations at different positions 
targeted by the oligonucleotide after addition of ApeKI compared to when ApeKI was 
not added into the PCR reaction. The comparison can be made between Figure 23 (A) 
before adding ApeKI where it shows the GCAGC and GCTGC which is highlighted with 
the box and Figure 23 (B) the Sanger sequencing chromatographs which shows GCACC 
and GCTCC sequence after adding ApeKI. The sequence below the graph represents the 
5’-end & 3’-end, on the oligo it follows the order of nucleotide enrichment from 5’ to 3’ 
direction on the oligonucleotide.  
This also represents the enrichment of dG-to-dC mutations is higher at ApeKI RS 
(restriction site) -1,2 positions which serve as a ‘control mismatch’ in the spore assay. 
 
Enrichment of GCWCC sequence from GCWGC (W= A or T) (mean + 
standard deviation, n =2) after successful oligonucleotide recombination 
into the E.coli genome. This shows that enriched dC-dC mismatches after 






While enrichment of dG-to-dC mutations at 5’ and 3’ represents the ‘probe mismatch’ of 
SPORE assay. 
From Table 1 we can see that enrichment of dG-to-dC mutations to 67% for 
flanking mutations and around 81.07% for mutations to the ApeKI restriction sites. When 
this data we compare with the oligo containing one ApeKI mutated site we can see the 
better enrichment of dG-to-dC mutations on the genome which is a little bit less compare 
to the 85% + 8.7% enrichment of plasmid DNA. This indicates that two mutated ApeKI 
recognition sites are the best to perform the genotypic selection on the genome which 
gives the highest enrichment of mismatches on the genomic DNA compared to the one 
mutated ApeKI recognition site. 
Conclusion: Above results indicate that the strategy to screen simultaneously for 
two mutated ApeKI recognition site mutations has worked significantly better than the 
screen using only one, and we got more efficient signals from the sequencing. We can see 
significantly stronger enrichment of all four mutations (two flanking the ApeKI sites) 
introduced by this oligonucleotide.  
This suggests that using two ApeKI separate recognition sites for genotypic 
screening helps to enrich the targeted mutations. We have reproduced these results two 
times. Thus, we confirmed that these oligonucleotides are the best to design the 
oligonucleotides for SPORE assay. 
3.2.4 SPORE Assay using Genotypic Selection: 
 
With the above findings that we could successfully enrich mutations introduced 




the SPORE assay. As we know from Figure 10 that SPORE assay [8] is a technique that 
allows us to study MMR process inside the cell. SPORE assay also helps to study the 
directionality of MMR [9] described in Figure 25. Here we attempted to test whether we 
could use ApeKI for a genotypic screening of SPORE assay. 
 
Figure 25. The Directionality of MMR on Lagging Strand in E.coli [9] 
 
 
(A)The probe mutation dG-dT (red color) excites MMR, while the control mutation 
protected by phosphorothioate bonds (black color) and a silent mutation dC-dC (blue 




(B) If the MMR is bidirectional then there is a 50% chance the silent mismatch (blue 
circle) will be repaired inadvertently by long-patch repair (LPR) as often as the probe 
mismatch (red circle).  
(C) If MMR is coupled to replication and unidirectional, then we would not expect the 
silent mismatch to be repaired during repair of the probe mismatch.  
(D) Represents the data that MMR is bidirectional and Long Patch Repair (LPR) is 
coordinated from 3’-side of DNA where probe mutation is repaired around 80% and 




In this study, we had two different oligos (Figure 26): Oligo 1 which one had 3’- 
site “MMR active (underlined)” probe mismatch, two protected (with phosphorothioate 
bonds labelled *) “control mismatches” and one unprotected “silent mismatch 
(underlined)” at 5’-site. Another oligo (oligo 2) had a 5’- site “MMR active” probe 
mismatch (underlined), two protected  “Control mismatches” and one unprotected “Silent 
mismatch (underlined)” at 3’-site.  
SPORE Oligo 1: 5’-CGT CAG TTA GCG CCG CAG TTA CCC GAT 
AT*G*C*A*C CAA AC GCTC*C*T*G* GAT AAA CAC TAT CTA CGT AAG CAT 
GGC GCG AAG GC-3’. SPORE Oligo 2: 5’-CGT CAG TTA GCG CCG CAG TTA 
CCA GAT AT*G*C*A*C CAA AC GCTC*C*T*G* GAT AAA CAC TAT CTC CGT 
AAG CAT GGC GCG AAG GC-3’ 
The oligos used for this study is different than they were used in Figure 25, where 
researcher used dG-dT mismatches as the probe and here we have used dC-dA as a probe 






Figure 26. SPORE Assay on araD Gene 
 
 
Representation of genomic lagging strand which is complementary to the genomic 
leading strand (no color), oligo-1(green) and oligo-2(no color) also. If no repair occurs. 
Blue boxes on the oligonucleotide indicate the phosphorothioate bonds to protect the 
control mismatches recognized by MMR proteins. Probe mutations are indicated with 
bold and underlined letters. Oligo-2 probe mismatches are indicated with purple color 
box. Red arrows indicate the targeted mismatches to the lagging strand. This Figure 
also shows the genomic DNA sequence after oligonucleotide incorporation. We have 
discussed the hypothesis and results in the next section after this on how this 
oligonucleotide will be repaired. [Blue boxes shows the presence of phosphorothioate 
bonds as protection for control mismatch, purple boxes shows the probe mismatch in 
oligo 2 while in oligo 1 probe mismatches are underlined outside of the 











Figure 27. The Outcomes of Different Hypotheses of How the Repair of Oligo-1 
could Occur After Incorporation 
 
 
We have strategically introduced dA-dC mismatches on the 3’ side of the oligonucleotide 
and dC-dC mismatch on the 5’ side of it. Now, if the MMR starts from the 5’ side and 
stops then only dC-dC will be converted to G-C base pair. On the other hand, if the 
MMR proteins repair only from 3’ side then dA-dC will be repaired to G-C base pair in 
the next round of replication. If MMR proteins work bidirectionally in the genome then 
both dA-dC and dC-dC will be converted to G-C base pair on the sides as showed in the 
Figure. [Blue boxes show the presence of phosphorothioate bonds as protection for 
control mismatch, oligo 1 probe mismatches are underlined outside of the 










Figure 28. The Outcomes of Different Hypotheses of How the Repair of Oligo-2 
could Occur After Incorporation 
 
 
In the oligo-2 we have strategically introduced dA-dC mismatch on the 5’ side of the 
oligonucleotide and dC-dC mismatch on the 3’ side of it. Now, if the MMR starts from 
the 3’ side and stops then only dC-dC will be converted to G-C. On the other hand, if 
the MMR proteins repair only from 5’ side then dA-dC will be repaired to G-C in the 
next round of replication. If MMR proteins work bidirectionally in the genome then 
both A-C and C-C will be converted to G-C on the sides as showed in the Figure. [Blue 
boxes show the presence of phosphorothioate bonds as protection for control 
mismatch, purple boxes shows the probe mismatch in oligo 2 outside of the 
















The Gel image was taken after the 2nd round of PCR with the addition of ApeKI 











Red arrows with numbers show the mutation that we selected for. (A) When oligo 1 
was inserted into the genome they have got repaired in which MMR activating 






oligonucleotide (B) When oligo 2 was inserted into the genome they got repaired by 
MMR. Here, MMR activating mismatch (dA-dC) was on the 5’- side and silent 
mismatch (dC-dC) was on the 3’-side on the oligonucleotide. 
 
 
Table 3.  Quantitative Values of Repaired and Mutated Mismatch on Oligo 1 
 
 
The quantitative analysis of selectively enriched mutations selected for ApeKI 
restriction sites-1,2 positions on the oligonucleotides.  
This also represents the percentage of dC-dC mismatch repair on the 5’-side and 
dA-dC mismatch repair on the 3’ side. The data represents the mean value and 
standard deviation of mutation at each site on the oligonucleotide without adding 





Figure 31. Bar Graph Obtained After Quantitative Analysis of SPORE Oligo 1 
 
 
Using oligo-1, Enrichment of dG-to-dC mutations (control) at the middle position 
while the repair of dA-dC and dC-dC (probe) mismatch on the 3’ and 5’ side of the 
oligonucleotide respectively (mean + 95% confidence interval, n = 3) after successful 
oligonucleotide recombination into the E.coli genome. This shows that enriched 




The sequence present in Figure 26 is a representation of Sanger sequencing 
chromatograph from Figure 30 (A) only. where it indicates the repair of dC-dC mismatch 
on the 5’ and 3’ end of the oligo. Moreover, the graph in Figure 31 represents the 
enrichment of dG-to-dC mutations is higher at ApeKI restriction sites -1,2 because they 
are protected as shown in the oligonucleotide sequence below the graph. 
From Table 3 we can see that maximum enrichment of dG-to-dC mutations in the 
middle with 92.34 + 2.40 (95% confidence interval).  
On the 3’-side the repair of dA-dC mismatch (showed as “G” on the 3’ bar of the 




of “A” nucleotide at 3’ bar indicate that dA-dC mismatch was occurred in the genome by 
our oligonucleotide but only 67.2% of the incorporated dA-dC mismatch was corrected at 
this site. Moreover, this data also indicate that the dC-dC mismatches (indicated as “G” at 
5’ bar of the graph), which presumably were repaired by Long-patch repair originating 
from the 5’- side in an attempt to repair the dA-dC mismatch, occurred 64.6% (1.9% 
confidence interval).  
Conclusion: The above SPORE assay data represent that E.coli MMR is 
coordinated in a bidirectional fashion and it has, presumably unintentionally through 
long-patch repair, repaired silent dC-dC mismatches on the 5’ side of the oligo as well as 
dA-dC mismatches on the 3’ side of the oligo-1. Thus, we can compare it with our 
hypothesis in Figure 27 and with published evidence (Figure 25) [9] which shows the 
sequence of oligonucleotide if the MMR was attempted from both the side. Moreover, if 
we compare this quantitative result with published Figure 25 (D) which indicate the 
repair of dG-dT probe mismatch around 80% at 3’ side of the oligonucleotide.  
While we see the repair of dA-dC mismatch at 3’ side which is on average 67% + 2.5% 
of the incorporated nucleotides. This shows the difference in the repair of two different 











Table 4. Quantitative Values of Repaired and Mutated Mismatch on Oligo 2 
 
 
The quantitative analysis of selectively enriched mutations selected for ApeKI 
restriction sites-1,2 on the oligonucleotides. This also represents the percentage 
of dC-dC mismatch repair on the 3’-side and dA-dC mismatch repair on the 5’ 
side. The data represents the mean value and standard deviation of mutation at 
each site on the oligonucleotide without adding ApeKI and after adding ApeKI 












Figure 32. Bar Graph Obtained After Quantitative Analysis of SPORE Oligo 2 
 
 
Using oligo-2, Enrichment of dG-to-dC mutations (control) at the middle position 
while the repair of dA-dC and dC-dC (probe) mismatch on the 5’ and 3’ side of the 
oligonucleotide respectively (mean + 95% confidence interval, n = 6) after successful 
oligonucleotide recombination into the E.coli genome. This shows that enriched dC-dC 
mismatches after addition of ApeKI during genotypic selection method. 
 
 
Figure 32 shows the enrichment of dC-dC mismatches at ApeKI restriction sites-
1,2 positions on the oligonucleotide after addition of ApeKI and this data can be 
compared to the Sanger sequencing chromatographs which show GCACC and GCTCC 
sequence after adding ApeKI. This data indicates the MMR activity on the SPORE oligo 
2 which has dA-dC probe mutation on 5’ side while the dC-dC silent probe mutation on 
3’side.  
In Figure 28 we can see two C nucleotide between two boxes, that represents the 
protection of these nucleotides and these nucleotides will not be recognized by MMR 
proteins as they are protected.  Also, this sequence is a representation of Sanger 




of dC-dC mismatch on the genome while the repair of dA-dC and dC-dC mismatch on 
the 5’ side and 3’ side respectively.  These data also indicate the total repair of dC-dC 
mismatches (indicated as “G” at 3’ bar of the graph) on an average of 79% with 6.11% 
confidence interval at the 3’ side of the oligonucleotide. On the other 5’-side the repair of 
dA-dC mismatch (showed as “G” on the 5’ bar of the graph) is an average of 71.7% with 
7.9% confidence interval. While the 10.55% presence of “A” nucleotide at 5’ bar indicate 
that dA-dC mismatch was occurred in the genome by our oligonucleotide but the only 
average of 71.7% of the incorporated dA-dC mismatch was corrected at this site.  
Conclusion: The above SPORE assay data represent that E.coli MMR is 
bidirectional in vivo and repair can be initiated from both 3’- and 5’- each with high 
efficiency, as it has repaired dC-dC silent mismatches on the 3’ side of the oligo as well 
as dA-dC mismatches on the 5’ side of the oligo. Thus, we can compare it with our 
hypothesis in Figure 28 and with published evidence (Figure 25) which shows the 
sequence of oligonucleotide if the MMR was attempted from both the side.  
3.2.4.1 Overall Conclusions from the SPORE Assay Experiments: 
 
For both oligos, dA-dC probe mismatches were repaired with high efficiencies from 
both 5’- and 3’-, which is in agreement with earlier results from SPORE assays using dG-
dT mismatches that those mismatches could be repaired with MMR coordinated from 
either direction in vivo. The repair of dA-dC mismatches was also less than dG-dT 
mismatches, which is expected given previous studies and the relative affinities of MutS 




What was unexpected was the significant repair of the ‘silent probe’ mismatches, 
which suggests repair of the dA-dC mismatches is being initiated from both 5’- and 3’- 
sides of the mismatch with approximately equal probabilities, in contrast to results that 
found that dG-dT mismatches were repaired primarily from the 3’- side. We consider 
possibilities for these differences between our results of the coordination of the probe 
mismatch: 
1. One possibility is that dA-dC mismatches are repaired by a different 
mechanism in vivo than dG-dT mismatches. Further investigation is necessary. 
2. Another possibility is that our results are based on the genotypic selection 
of a mutation while the previous assay used phenotypic selection on selective minimal 
media. It may be possible that the silent mismatch, although it introduced a ‘silent 
mutation’ where the sequence changed but the same amino acid was coded for, 
introduced a selective pressure during the phenotypic assay that interfered with the 
results. This is one reason we are developing a genotypic screen in the first place.  
3. Another possibility is that the earlier study was performed within the galK 
gene while this experiment was performed to mutate sequences in the araD gene. These 
genes both have different locations on the E.coli genome and positions relative to nearby 
d(GATC) sites. So, a repair could have been coordinated different based on those two 
factors as well. Further investigation is necessary. 
From Figure 30, which shows the chromatographs of SPORE assay results 
performed with oligo 1 and oligo 2. Upon examination, we noticed some unusual signals 




the dA-dC mismatch sites which could not be explained by long-patch repair. Generally, 
dA-dC mismatch should get repaired to dG-dC base pairing but in our results, but there 
was a signal indicating a dC-dG basepair. This activity was observed only with the repair 
of dA-dC mismatch on both oligos at 3’ side on oligo 1 and 5’ side of oligo 2. We assume 
that one of the possibilities of this signal after repair can be human error, or errors at the 
manufacturing level so the oligos could be contaminated. This repair interferes with our 
data of quantifying repair of dC-dC mismatch on the oligonucleotide and suggests there 
is some level of contamination between oligo 1 and oligo 2 that could have occurred 
either at the production level, purification level, or at transfection level. So, for this, we 
recalculated the frequency of dC signal at dA-dC sites, which would indicate the level of 
contamination, to estimate the range of possible repairs at the ‘silent mutation’ site, since 
contamination would have increased the apparent level of repair at that site by the same 
amount.  
For oligo 1 the recalculated estimate of the repair of the silent mutation is from 
49.9% (4.28, 95% confidence) To the original value of 67.23% (2.50%, 95% confidence) 
while for oligo 2 the estimated repair of the silent mutation ranged from 62.2% (10.81, 
95% confidence interval) To the original value of 71.7% (7.99%,95% confidence). This 










Table 5. The Estimated Range of Silent Mutation Repair Efficiencies 
 
  
These values are calculated from the quantitative analysis of dC-dC mismatch on both 
oligos 1 & 2. This is recalculated by subtracting the dC-dC mismatch repair at the site 
of dA-dC mismatch repair. The data represents the range of dC-dC mismatch repair 
from (X%-values after correction to Y% values before correction). 
 
 
Above all the results indicate that MMR repair can be initially coordinated 
bidirectionally on the lagging strand as we can see the repair of probe mutations on 5’- 
side as well as 3’-side approximately equally under certain conditions. We have further 
noticed the difference in the repair of dA-dC mismatch when it is present on the 3’side 
and 5’ side of the oligonucleotide. The same difference we see in the repair of dC-dC 
mismatch too. As we see the difference in dA-dC probe mismatch compared to the 




We know that dG-dT and dA-dC mismatch can excite the MMR process in the 
cell but from the quantitative analysis, we see the difference in their repair. We assume 
that one of the possibility of MutS binding to the different mismatches. MutS binds to 
different mismatches from highest binding to weakly binding according to dG-dT, dA-
dC, dA-dA, dG-dG >  dT-dT, dT-dC, dA-dG >> dC-dC. In this, we have seen that 
mismatch repair was attempted from the opposite side of the ‘probe mutation’ in both the 
cases which is an addition to the previous study, [9] where it is shown that LPR is 
coordinated from the same side where ‘probe mutation’ was present as indicated in 
Figure 25. Now, with the help of this study, we can quantify the repair efficiency of dA-
dC mismatch repair which was not measured previously.  
With these experiments, our trial was to develop new biotechnology to study the 
DNA MMR in cells. We see that our new method of genotypic selection with mutation 
enrichment using ApeKI during PCR reaction has worked well and has proven the 
hypothesis shown in Figure 25(B) studies of SPORE assay.  
Thus, we can conclude that we can pull out the rare genomic mutation with this 
new technique as well as we can study the mismatch repair process quickly without 







SUMMARY AND FUTURE DIRECTIONS 
 
 
Here, we have shown the development of a genotypic selection to screen for the 
rare genomic DNA mutations without growing bacteria on selective media, using PCR 
and a thermotolerant restriction enzyme. We have seen the maximum of 705,000-fold 
enrichment of the selected plasmid DNA even in 10-6 times dilution. We have shown that 
this method can also be used to screen for mutations introduced by oligonucleotide 
recombination with high frequency using three different oligos. This method can be 
combined with SPORE assay to study the MMR quantitatively. The results we found 
provided interesting validations as well as discrepancies when we compared it with 
previously published work that used phenotypic screens and are worthy of further 
investigation.  
While the experimental work for this dissertation was unfortunately cut short by 
the outbreak of the COVID-19 pandemic, future work would be focused on: 
1. Further optimization and validation of the sensitivity of this technique and 




2. Using SPORE assays with genotypic screens and strains of E. coli with 
mutations to MMR proteins to understand if replication-independent and replication-
dependent MMR processes are coordinated similarly or differently. 
3. Using genotypic screens to allow for time-dependent studies of MMR as it 
occurs in living cells. Phenotypic screens require several generations for successful 
screening, while the genotypic screen can be performed before a single replication event 
has occurred after oligonucleotide incorporation. 
4. The SPORE assay in other organisms where oligonucleotide 
recombination success might be poor or phenotypic screens might be difficult, like 
actinomyces which have important applications to human health and biotechnology.  
The new biotechnology developed during this thesis paves the way for those 
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